FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32899011000001107: Daclatasvir 90mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100230901000001118 Daclatasvir 90mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100231001000001110 Daclatasvir 90mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclatasvir 90mg tablets Has specific active ingredient Daclatasvir dihydrochloride true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Is a Daclatasvir true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Plays role Antiviral therapeutic role true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Is a Product containing daclatasvir false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has active ingredient Daclatasvir false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has specific active ingredient Daclatasvir dihydrochloride false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Daclatasvir false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has basis of strength substance Daclatasvir false Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a True Daclatasvir 90mg tablets Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets 28 tablet Has VMP True Daclatasvir 90mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start